Subconjunctival Bupivacaine in Strabismus Surgery

Fayoum University

Status: Unknown

Conditions: Anesthesia, Local

Treatments: Drug: Iocal anaesthetic bupivacaine; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT04782960

Subconjunctival bupivacaine

Details and patient eligibility

About

This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.

Full description

40 patients will schedule for elective Strabismus surgery under general anaesthesia and randomly allocated into two groups to receive Subconjunctival 0.5%Bupivacaine group(B) or Subconjunctival placebo 0.9% normal saline group at the end of the surgery and assess the postoperative pain at 0th,30th, 60th,2nd h, 4h,6h,12h,24h.and post operative nausea and vomiting.

Enrollment: 40 estimated patients

Sex: All

Ages: 14 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All patients aged 14 _30 years old with body mass index 18_28kg/m.
• American Anaesthesiologist Association physical states I,II.
• singed informed consent to participate in the study and were scheduled for strabismus operations under general anaesthesia.

Exclusion criteria

• were patients with chronic pain.
• ocular hypertension.
• inability to communicate.
• history of hematological disease.
• allergy to local anesthetic drugs.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups, including a placebo group

20 patients receive Subconjunctival bupivacaine of the end of the surgery

Active Comparator group

Description:

20 patients receive Subconjunctival bupivacaine in the end of operation and monitoring postoperative pain score

Treatment:

Drug: Iocal anaesthetic bupivacaine

20 patients receive Subconjunctival placebo in the end of operation

Placebo Comparator group

Description:

20 patients receive Subconjunctival placebo in the end of operation and monitoring postoperative pain score

Treatment:

Drug: Placebo